Bafna Pharmaceuticals Ltd

NSE: BAFNAPH · BSE: 532989 · Pharmaceuticals & Biotechnology · 13 announcements

Share price: ₹482.25
Market cap: ₹1,141 Cr
Revenue (annual): ₹150.6 Cr
Net profit (annual): ₹11.10 Cr
P/E (TTM): 99.1×Sector 43.8×
Promoter holding: 75.00%+0.00% QoQ
FII holding: 9.34%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

11 Nov 2026 16:46 IST BSE

Financial ResultsAlfa Alert

Bafna Pharmaceuticals Q2 FY27 Results: Net Profit ₹6.8 Cr, Up 119.4% YoY

Bafna Pharmaceuticals' board approved unaudited financial results for the quarter and half year ended 30 September 2026, with a limited review report. Quarterly revenue from operations was ₹47.67 Crore, versus ₹35.47 Crore a year earlier.

Key figure: Net profit ₹6.8 Cr · +119.4% YoY

Open full results → Read the filing ↗